Drug Eluting Stent

Drug Eluting Stent - most related articles:

- Drug eluting stents prove more effective - 11.6
- Certain drug coated stents may be safe, effective - 11.1
- Prasugrel cuts risk of stent-related clots - 10.2
- Stent design may put patients at risk of heart attack - 6.5
- Benefits of anti clotting medications reduced by heartburn drugs - 4.9
- Stroke clinical trial finds intensive medical treatment better than brain stent - 4.6
- Coronary artery bypass graft surgeries decreasing in US - 4.3
- FDA will review Daiichi Sankyo, Lilly drug Prasugrel for heart attack - 4.1
- Effient to reduce heart attack risk in angioplasty patients - 3.2

Drug Eluting Stent articles

Drug eluting stents prove more effective
The Cardiovascular Research Foundation (CRF) announced that its landmark study comparing the safety and efficacy of drug-eluting stents and bare-metal stents was published in The New England Journal of Medicine.

Prasugrel cuts risk of stent-related clots
The investigational antiplatelet drug prasugrel plus aspirin produced a marked and highly statistically significant reduction in the risk of coronary stent thrombosis (ST) - a major concern for physicians and patients with potentially fatal consequences - in patients who received a stent as compared to standard therapy with clopidogrel (Plavix) plus aspirin, according to a stent analysis from the head-to-head TRITON-TIMI 38 trial.

2 Drug Eluting Stent articles listed above.

List health news, Health organizations, Health news world, Glossary, Best health articles, Featured     Go to top

The information provided on Health Newstrack is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. We comply with the HONcode principles for trustworthy health information, and Health News Track is hon code accredited, verify here.
About us, Site map Privacy policy, Disclaimer
© 2007, 2008, 2009, 2010, 2011 HealthNewsTrack.com
3.81